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Review question
1- What is the prevalence of medication errors associated with novel oral anticoagulants in adult patients?
2- What are the key factors associated with errors while using novel oral anticoagulants use in adult
patients?
3- What are the nature and effectiveness of interventions to minimize and prevent medication errors
associated with novel oral anticoagulants in adult patients?
 
Searches
Independent and duplicate data extraction will be undertaken. The results of all searches will be exported
into a reference manager database using Endnote X9 software for double screening titles and abstracts then
will remove duplicated studies and use the rest for referencing later. Any disagreement or uncertainties about
study inclusion will be resolved by discussion and consensus of the reviewer and referred to a third reviewer
if required for elucidation and clarify of information. The study selection will be a three stage process;
reasons for exclusion will be documented at full text screening stage.
Stage 1: initial screening of titles all retrieved studies will be considered alongside inclusion and exclusion
criteria. Studies which are clearly not relevant will be excluded, as those that initially considered relevant but
will be excluded on the basis of inclusion and exclusion criteria. Where there are any doubts, studies will be
included at this stage.
Stage 2: screening of abstracts retained studies will be accessed and their relevance assessed according to
the inclusion and exclusion criteria. Where there are any doubts, studies will be included.
Stage 3: assessment of full text all studies retained at stage 2 above will be obtained and their relevance
assessed according to the inclusion and exclusion criteria.
The search in databases will be run from 2008 to 2019.
A systemic search of literature will be undertaken in ten electronic database:MEDLINE, Embase
The Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic Reviews
(CDSR)
Database of Abstracts of Reviews of Effects (DARE), Cumulative Index to Nursing and Allied Health
Literature (CINAHL), The British Nursing Index (BNI), International Pharmaceutical Abstracts (IPA), Health
Management Information Consortium (HMIC), Google Scholar.
Other web based searches :The national medication error reporting systems of JCAHO Sentinel Events
Reporting System, Medication Errors Reporting Program (ISMP), USP MedMARx™ Program and the FDA
MedWatch™ Program.
 
Types of study to be included
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All study designs will be considered. These include:
• Randomised controlled trials, 
• Non-randomised controlled studies, 
• Before-and-after study, 
• Interrupted time series,
• Cohort study, 
• Case-control study 
• Case series in relation to prevalence of medication errors and effectiveness of interventions to prevent or
minimise errors, 
• Qualitative studies- Including Narrative, phenomenology, grounded theory ethnography, case studies, and
action research will be included in relation to the data around factors contributing to the errors, and
preventing minimizing errors.
• Mixed methods design will aso be included.
• Intervention studies including RCTs, non-randomised controlled studies, 
 
Condition or domain being studied
Medication errors associated with non-vitamin K antagonist oral anticoagulants (NOACs).
 
Participants/population
All adult patients ? 18years using any of NOACs
 
Intervention(s), exposure(s)
Non-vitamin K antagonist oral anticoagulants (NOACs).
 
Comparator(s)/control
Usual care (without that intervention) for intervention studies.
 
Context
All study settings will be considered.
 
Main outcome(s)
-Prevalence and number of medication errors
-Contributing factors 
-Error rate 
-Patient quality of life
-Hospitalisation rate
-Mortality
-Morbidity- 
-Prevention measure
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Additional outcome(s)
None.
 
Data extraction (selection and coding)
Electronic data extraction forms will be prepared based on the review questions and objectives and in
consultation with research team members. The forms will be piloted before use. The fields will include: Study
title and author/s, setting, study design, number of patients in each group, and outcome of significance to the
review question and objectives. In addition, data on the use of theory and theoretical frameworks will be
extracted.
The data extraction tools will be developed and summarised in tabulated format.
 
Risk of bias (quality) assessment
Risk of bias assessment (RCTs):
The Cochrane risk of bias assessment tool (2008) to assess the quality of randomised control trials (RCT)
will be utilised. Risk of bias in all included studies will be assessed and reviewed by two independent
reviewers and third reviewer will be consulted if consensus cannot reached. Each included studies will be
assessed and evaluated according to the following criteria: Sequence generation, allocation concealment,
blinding of participants and personnel used throughout the study, completeness of data, and selective
outcome reporting and other source of bias
Quality assessment (non-RCT studies):
For the methodological quality of non-RCTs, Newcastle-Ottawa Scale (NOS) that was developed and
validated mainly for observational studies will be used for non-RCT studies. The NOS evaluates three quality
parameters (selection, comparability, and outcome) divided across eight specific items.
Another alternative tool used for to assess the quality of cohort is the GRACE checklist. This tool can
adequately assess the comparative effectiveness investigated in comparative studies. Also the checklist
provides a good assessment of the scientific methods used by a study as well as an assessment on the
quality of data used in a study. Therefore, this review will utilise this tool for studies with comparative groups.
 
Strategy for data synthesis
Analysis depends on the data available but involves a form of narrative synthesis so as to deduce and
concisely explain the findings of studies included in this review. First, a descriptive summary of studies will
be presented in table form supported by a narrative description of the findings in each included study. The
tables will include details of study type, setting, and numbers of participants, outcomes of interest, findings
and an indication of study quality to assess the integrity of the result will be produced.
Meta-analysis of quantitative data will be considered where relevant. This will apply to data in relation to
prevalence and interventions studies.
 
Analysis of subgroups or subsets
None.
 
Contact details for further information
Dr.Vibhu Paudyal
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